Fri 4/3/2020 07:29 ET
DJIA21413.44479.662.24%TELCO160.815.103.17%GOLD1630.557.170.44%Shanghai2771.349.150.33%
S&P 5002526.9057.612.28%BANKS291.898.412.88%OIL26.411.094.13%BITCOIN6961.04169.152.43%
NASDAQ7487.31128.781.72%PHARM553.2017.483.16%US/EU1.080.000.01%Futures2489.6226.891.08%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Bellerophon Therapeutics - BLPH   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add BLPH
  
From: pedley (Rep: 27)Date: 05/21/2019 08:42
Forum: Bellerophon Therapeutics - Msg #542Thread #674082588 (Rec: 0)
Bellerophon Presents Additional Positive Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulseĀ® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at American Thoracic Society 115th International Conference

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser pedley: Reward | Watch | IgnoreBLPH: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add BLPH
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.